Skip to Main Content

Author Details

Anna-Lena Volckmar
Institut fur Pathologie, Universitatsklinikum Heidelberg
2010
83
26
PMIDPaper TitleJournal TitlePublished Year
36635225First proficiency testing for NGS-based and combined NGS- and FISH-based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma.J Pathol Clin Res2023
37792098[Regulation (EU) 2017/746 (IVDR): practical implementation of annex I in pathology].Pathologie (Heidelb)2023
37586177Analysis of rare fusions in NSCLC: Genomic architecture and clinical implications.Lung Cancer2023
34331337Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicine.Genes Chromosomes Cancer2022
35871236Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing.Br J Cancer2022
35925306[Structure and content of the EU-IVDR : Current status and implications for pathology].Pathologie (Heidelb)2022
35879369Evidence for correlations between BMI-associated SNPs and circRNAs.Sci Rep2022
33971666Knowledge bases and software support for variant interpretation in precision oncology.Brief Bioinform2021
33686791KRAS/GNAS-testing by highly sensitive deep targeted next generation sequencing improves the endoscopic ultrasound-guided workup of suspected mucinous neoplasms of the pancreas.Genes Chromosomes Cancer2021
33715240RREB1-MKL2 fusion in a spindle cell sinonasal sarcoma: biphenotypic sinonasal sarcoma or ectomesenchymal chondromyxoid tumor in an unusual site?Genes Chromosomes Cancer2021
33667718Targeting rare and non-canonical driver variants in NSCLC - An uncharted clinical field.Lung Cancer2021
34408792Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancer.Ther Adv Med Oncol2021
34605937Erratum zu: Varianteninterpretation in dermolekularen Pathologie und Onkologie.Pathologe2021
33938987[Variant interpretation in molecular pathology and oncology : An introduction].Pathologe2021
34073477Complete Metabolic Response in FDG-PET-CT Scan before Discontinuation of Immune Checkpoint Inhibitors Correlates with Long Progression-Free Survival.Cancers (Basel)2021
34125166Knowledge bases and software support for variant interpretation in precision oncology.Brief Bioinform2021
34012783Conventional and semi-automatic histopathological analysis of tumor cell content for multigene sequencing of lung adenocarcinoma.Transl Lung Cancer Res2021
33959513Feasibility and Challenges for Sequential Treatments in ALK-Rearranged Non-Small-Cell Lung Cancer.Front Oncol2021
33976623Combination of Crizotinib and Osimertinib in T790M+ EGFR-Mutant Non-Small Cell Lung Cancer with Emerging MET Amplification Post-Osimertinib Progression in a 10-Year Survivor: A Case Report.Case Rep Oncol2021
34164264Earlier extracranial progression and shorter survival in ALK-rearranged lung cancer with positive liquid rebiopsies.Transl Lung Cancer Res2021
32212351Immuno-oncology gene expression profiling of formalin-fixed and paraffin-embedded clear cell renal cell carcinoma: Performance comparison of the NanoString nCounter technology with targeted RNA sequencing.Genes Chromosomes Cancer2020
31970771Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary.Int J Cancer2020
31925805Genomic Characterization of Cholangiocarcinoma in Primary Sclerosing Cholangitis Reveals Therapeutic Opportunities.Hepatology2020
33161228Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA.EBioMedicine2020
32871455Risk stratification of EGFR<sup>+</sup> lung cancer diagnosed with panel-based next-generation sequencing.Lung Cancer2020
32280037High prevalence of DNA damage repair gene defects and TP53 alterations in men with treatment-naïve metastatic prostate cancer -Results from a prospective pilot study using a 37 gene panel.Urol Oncol2020
30306707Gain-of-function variants in the melanocortin 4 receptor gene confer susceptibility to binge eating disorder in subjects with obesity: a systematic review and meta-analysis.Obes Rev2019
31753813Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in <i>KLC1-ALK</i>-rearranged lung cancer.Cold Spring Harb Mol Case Stud2019
30216696Digital PCR After MALDI-Mass Spectrometry Imaging to Combine Proteomic Mapping and Identification of Activating Mutations in Pulmonary Adenocarcinoma.Proteomics Clin Appl2019
30238975Size matters: Dissecting key parameters for panel-based tumor mutational burden analysis.Int J Cancer2019
30230086Next generation sequencing of the cellular and liquid fraction of pancreatic cyst fluid supports discrimination of IPMN from pseudocysts and reveals cases with multiple mutated driver clones: First findings from the prospective ZYSTEUS biomarker study.Genes Chromosomes Cancer2019
31491926RNA-Based Detection of Gene Fusions in Formalin-Fixed and Paraffin-Embedded Solid Cancer Samples.Cancers (Basel)2019
31349062Spatial and Temporal Heterogeneity of Panel-Based Tumor Mutational Burden in Pulmonary Adenocarcinoma: Separating Biology From Technical Artifacts.J Thorac Oncol2019
31549213The BRCA2 mutation status shapes the immune phenotype of prostate cancer.Cancer Immunol Immunother2019
31008532Variant classification in precision oncology.Int J Cancer2019
31089797[From panel diagnostics to comprehensive genomic analysis : Infobesity or empowerment?]Pathologe2019
30963573Comparative genetic profiling aids diagnosis and clinical decision making in challenging cases of CUP syndrome.Int J Cancer2019
30653256Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: Analysis of the first 3,000 Heidelberg cases.Int J Cancer2019
30669647Detection of TP53 Mutations in Tissue or Liquid Rebiopsies at Progression Identifies ALK+ Lung Cancer Patients with Poor Survival.Cancers (Basel)2019
30446996Measurement of tumor mutational burden (TMB) in routine molecular diagnostics: in silico and real-life analysis of three larger gene panels.Int J Cancer2019
27367046High-throughput DNA methylation analysis in anorexia nervosa confirms TNXB hypermethylation.World J Biol Psychiatry2018
35135162Validating Comprehensive Next-Generation Sequencing Results for Precision Oncology: The NCT/DKTK Molecularly Aided Stratification for Tumor Eradication Research Experience.JCO Precis Oncol2018
30134862Relevance of polymorphisms in MC4R and BDNF in short normal stature.BMC Pediatr2018
30348504Genetic profiling of melanoma in routine diagnostics: assay performance and molecular characteristics in a consecutive series of 274 cases.Pathology2018
30454709Immunotherapy with ipilimumab plus nivolumab in a stage IV melanoma patient during pregnancy.Eur J Cancer2018
30505715Implementing tumor mutational burden (TMB) analysis in routine diagnostics-a primer for molecular pathologists and clinicians.Transl Lung Cancer Res2018
29631267The Effect of SH2B1 Variants on Expression of Leptin- and Insulin-Induced Pathways in Murine Hypothalamus.Obes Facts2018
29205637A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.Genes Chromosomes Cancer2018
29269125Targeted molecular profiling reveals genetic heterogeneity of poromas and porocarcinomas.Pathology2018
29044880Targeted deep sequencing of effusion cytology samples is feasible, informs spatiotemporal tumor evolution, and has clinical and diagnostic utility.Genes Chromosomes Cancer2018
  • 1 - 50 of 83

Recommended Authors

Nayoung K D Kim
Samsung Genome Institute, Samsung Medical Center
Career Start Year 2013
Number of shared co-authors 0
Kuan-Lin Huang
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 0
John D Overton
Regeneron Pharmaceuticals
Career Start Year 2008
Number of shared co-authors 1
Hui Zhao
College of Life Sciences, University of Chinese Academy of Sciences
Career Start Year 2007
Number of shared co-authors 0
Sigve Nakken
University of Oslo
Career Start Year 2007
Number of shared co-authors 6
Katia Nones
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 0
Mark J Cowley
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2006
Number of shared co-authors 2
Danielle M Greenawalt
Bristol-Myers Squibb Co.
Career Start Year 2006
Number of shared co-authors 7
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 6
Alison Meynert
Institute of Genetics and Cancer, University of Edinburgh
Career Start Year 2006
Number of shared co-authors 0
Ann-Marie Patch
QIMR Berghofer Medical Research Institute
Career Start Year 2005
Number of shared co-authors 6
Robert C Onofrio
The Broad Institute of Harvard and MIT
Career Start Year 2005
Number of shared co-authors 4
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 1
Laurie Burdett
National Cancer Institute, Frederick National Laboratory for Cancer Research
Career Start Year 2005
Number of shared co-authors 0
Abul Kalam Azad
University of Dhaka
Career Start Year 2004
Number of shared co-authors 0
Rebecca Nagy
Guardant Health Inc.
Career Start Year 2004
Number of shared co-authors 4
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 0
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 5
Stacey Gabriel
Broad Institute of MIT and Harvard
Career Start Year 2001
Number of shared co-authors 16
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 5
Eric W Klee
Mayo Clinic College of Medicine and Science
Career Start Year 2001
Number of shared co-authors 2
Yan W Asmann
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 1
Hugues Sicotte
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 2
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 1
Dirce Maria Carraro
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Carrie Sougnez
The Broad Institute of Harvard and MIT
Career Start Year 1998
Number of shared co-authors 2
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 0
John V Pearson
QIMR Berghofer Medical Research Institute
Career Start Year 1996
Number of shared co-authors 6
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 0
Katherine L Nathanson
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Career Start Year 1986
Number of shared co-authors 3

Collaborators

Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 54
Peter Schirmacher
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 43
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 38
Martina Kirchner
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 29
Anke Hinney
University Hospital Essen, University of Duisburg-Essen
Co-authored papers 28
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 22
Johannes Hebebrand
LVR-Universitatsklinikum Essen, Kliniken und Institut der Universitat Duisburg-Essen
Co-authored papers 22
Olaf Neumann
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 22
Daniel Kazdal
Institut fur Pathologie, Universitatsklinikum Heidelberg
Co-authored papers 20
Michael Allg??uer
Institute of Pathology, Heidelberg University Hospital
Co-authored papers 19
Holger S??ltmann
German Cancer Research Center (DKFZ)
Co-authored papers 13
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Co-authored papers 12
Harald Grallert
Co-authored papers 7
H-Erich Wichmann
Co-authored papers 6
Ivo Buchhalter
German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Co-authored papers 6
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Co-authored papers 5
Thomas Illig
Co-authored papers 5
Frederick Klauschen
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Co-authored papers 5
Heike Biebermann
Co-authored papers 5
Esther Herpel
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 5
Huriye Seker-Cin
Institute of Pathology, Heidelberg University Hospital
Co-authored papers 4
Martin Klingenspor
Technical University of Munich
Co-authored papers 4
Thomas Longerich
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 4
Stefan Schreiber
Co-authored papers 4
Markus M N??then
Institute of Human Genetics, University Hospital Bonn
Co-authored papers 3
Karl-Heinz Jöckel
Co-authored papers 3
Sebastian Uhrig
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Co-authored papers 3
Andreas Reif
University Hospital Frankfurt am Main
Co-authored papers 3
Thomas W Winkler
Co-authored papers 3
Matthias Schlesner
University of Augsburg
Co-authored papers 3
Release 1.2